The reality behind cannabidiol’s medical hype

Michael Eisenstein

Nature, 2019, vol. 572, issue 7771, S2-S4

Abstract: The cannabis compound known as CBD is being touted as a treatment for a variety of conditions. But the substance’s uncertain legal status is stalling serious investigation.

Keywords: Policy; Therapeutics; Natural products (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-019-02524-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:572:y:2019:i:7771:d:10.1038_d41586-019-02524-5

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-019-02524-5

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().